ロード中...
New cast for a new era: preclinical cancer drug development revisited
Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and mortality in patients with cancer. However, despite an urgent need for more effective anticancer compounds, current preclinical drug evaluations largely fail to satisfy the demand. New preclinical strategies,...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3754257/ https://ncbi.nlm.nih.gov/pubmed/23999436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI68340 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|